Evidence map›Paper›PMID 30194803›Full record

ArticleJournal of thrombosis and haemostasis : JTH2018

Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.

T J Girard, K Grunz, N M Lasky, J P Malone, G J Broze

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The contribution of TFPIα to the hemostatic response to injury in mice.Journal of thrombosis and haemostasis : JTH · 2021
    Article
  9. Article
  10. Defective fibrin deposition and thrombus stability in BambiJournal of thrombosis and haemostasis : JTH · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

T J GirardDivision of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
K GrunzDivision of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
N M LaskyDivision of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
J P MaloneProteomics Core Laboratory, Institute of Clinical and Translational Sciences, Washington University School of Medicine, St. Louis, MO, USA.
G J BrozeDivision of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Washington University in St. Louis · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
Translational Research Skills Development CoreU54HL112303 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2012 to 2016
$8.8M
TFPI ALPHA AND TFPI BETAR37HL077193 · NHLBI · WASHINGTON UNIVERSITY · PI BROZE, GEORGE J · 2009 to 2018
$3.9M
TFPIalpha and TFPIbetaR01HL077193 · NHLBI · WASHINGTON UNIVERSITY · PI BROZE, GEORGE J · 2004 to 2007
$1.4M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NHLBI NIH HHS R01 HL077193NHLBI NIH HHS R37 HL077193NHLBI NIH HHS U54 HL112303NIGMS NIH HHS P41 GM103422
6 · The paper itself

Abstract

Essentials Mouse models are often used to define roles of tissue factor pathway inhibitor (TFPI) in man. TFPI isoform-specific KOs reveal unexpected differences between mouse and human TFPI physiology. Mouse plasma contains 20 times more TFPI than man, derived from TFPIγ, a form not found in man. TFPIγ null mice, expressing only TFPI isoforms α and β, may better reflect the human situation. SUMMARY: Background Mouse models can provide insight into the pathophysiology of human thrombosis and hemostasis. Tissue factor pathway inhibitor (TFPI) regulates coagulation through protein S (PS)-enhanced factor (F) Xa inhibition and FXa-dependent inhibition of FVIIa/tissue factor (TF) activity. TFPI is expressed as isoforms α and β in man, and α, β and γ in the mouse. Objective Assess the reliability of extending TFPI-related studies in mice to humans. Method Compare mouse and human TFPI physiology using a variety of methods. Results Mouse TFPI and human TFPI are similar in regard to: (i) the mechanisms for FVIIa/TF and FXa inhibition; (ii) TFPIα is a soluble form and TFPIβ is glycosyl phosphatidyl inositol (GPI) membrane anchored; (iii) the predominant circulating form of TFPI in plasma is lipoprotein-associated; (iv) low levels of TFPIα circulate in plasma and increase following heparin treatment; and (v) TFPIα is the isoform in platelets. They differ in that: (i) mouse TFPI circulates at a ~20-fold higher concentration; (ii) mouse lines with isolated isoform deletions show this circulating mouse TFPI is derived from TFPIγ; (iii) sequences homologous to the mouse TFPIγ exon are present in many species, including man, but in primates are unfavorable for splicing; and (iv) tandem mass spectrometry (MS/MS) detects sequences for TFPI isoforms α and β in human plasma and α and γ in mouse plasma. Conclusion To dissect the pathophysiological roles of human TFPIα and TFPIβ, studies in TFPIγ null mice, expressing only α and β, only α or only β should better reflect the human situation.

Indexed as

3' Untranslated RegionsAnimalsBlood PlateletsCRISPR-Cas SystemsDisease Models, AnimalGene DeletionGlycosylphosphatidylinositolsHemostasisHumansLipoproteinsMiceMice, Inbred C57BLMice, KnockoutProtein IsoformsRecombinant ProteinsSpecies Specificity3' Untranslated RegionsGlycosylphosphatidylinositolslipoprotein-associated coagulation inhibitorLipoproteinsProtein IsoformsRecombinant Proteinsalternative splicinghemostasismiceprotein isoformsthrombosis

Identifiers

PMID30194803
PMCPMC6235150
OpenAlexW2890721701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.